Cephalochromin, a FabI-directed antibacterial of microbial origin

Cited 34 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorC J Zheng-
dc.contributor.authorMi Jin Sohn-
dc.contributor.authorSangku Lee-
dc.contributor.authorYoung-Soo Hong-
dc.contributor.authorJ H Kwak-
dc.contributor.authorWon Gon Kim-
dc.date.accessioned2017-04-19T09:07:59Z-
dc.date.available2017-04-19T09:07:59Z-
dc.date.issued2007-
dc.identifier.issn0006-291X-
dc.identifier.uri10.1016/j.bbrc.2007.08.144ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/8060-
dc.description.abstractMicroorganisms produce many kinds of antibiotics which function in an antagonistic capacity in nature where they have much competition. Bacterial enoyl-acyl carrier protein (ACP) reductase (FabI) has been demonstrated to be an antibacterial target. However, no FabI-directed antibiotic of microbial origin has been reported so far. In this study, we found that cephalochromin with a naphtho-γ-pyrone skeleton, a fungal secondary metabolite, inhibited FabI of Staphylococcus aureus and Escherichia coli with IC50 of 1.9 and 1.8 μM, respectively. The methylether derivatives of cephalochromin, however, did not inhibit FabI. The FabI-inhibitory activities of cephalochromin and its derivatives well correlated with antibacterial activity as well as the inhibition of cellular fatty acid biosynthesis. Furthermore, FabI-overexpressing S. aureus exhibited reduced susceptibility to cephalochromin compared to the wild-type strain, demonstrating that the mode of antibacterial action of cephalochromin is via the inhibition of FabI. These results indicate that cephalochromin is the first FabI-directed antibacterial of microbial origin and may have the potential for further antibacterial development.-
dc.publisherElsevier-
dc.titleCephalochromin, a FabI-directed antibacterial of microbial origin-
dc.title.alternativeCephalochromin, a FabI-directed antibacterial of microbial origin-
dc.typeArticle-
dc.citation.titleBiochemical and Biophysical Research Communications-
dc.citation.number4-
dc.citation.endPage1112-
dc.citation.startPage1107-
dc.citation.volume362-
dc.contributor.affiliatedAuthorMi Jin Sohn-
dc.contributor.affiliatedAuthorSangku Lee-
dc.contributor.affiliatedAuthorYoung-Soo Hong-
dc.contributor.affiliatedAuthorWon Gon Kim-
dc.contributor.alternativeNameZheng-
dc.contributor.alternativeName손미진-
dc.contributor.alternativeName이상구-
dc.contributor.alternativeName홍영수-
dc.contributor.alternativeName곽진환-
dc.contributor.alternativeName김원곤-
dc.identifier.bibliographicCitationBiochemical and Biophysical Research Communications, vol. 362, no. 4, pp. 1107-1112-
dc.identifier.doi10.1016/j.bbrc.2007.08.144-
dc.subject.keywordAntibacterial-
dc.subject.keywordCephalochromin-
dc.subject.keywordEnoyl-ACP reductase-
dc.subject.keywordFabI-
dc.subject.keywordFatty acid synthesis-
dc.subject.keywordNaphtho-γ-pyrone-
dc.subject.localAntibacterials-
dc.subject.localantibacterials-
dc.subject.localantibacterial-
dc.subject.localAntibacterial-
dc.subject.localCephalochromin-
dc.subject.localEnoyl-ACP reductase-
dc.subject.localenoyl-ACP reductase-
dc.subject.localFabI-
dc.subject.localfatty acid synthesis-
dc.subject.localFatty acid synthesis-
dc.subject.localNaphtho-γ-pyrone-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Chemical Biology Research Center > 1. Journal Articles
Division of Research on National Challenges > Infectious Disease Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.